Form 8-K - Current report:
SEC Accession No. 0001641172-25-017370
Filing Date
2025-07-01
Accepted
2025-07-01 16:30:41
Documents
12
Period of Report
2025-06-25
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 49413
  Complete submission text file 0001641172-25-017370.txt   214153

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE cocp-20250625.xsd EX-101.SCH 3035
3 XBRL LABEL FILE cocp-20250625_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE cocp-20250625_pre.xml EX-101.PRE 22372
14 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3586
Mailing Address 19805 N. CREEK PARKWAY BOTHELL WA 98011
Business Address 19805 N. CREEK PARKWAY BOTHELL WA 98011 (786) 459-1831
Cocrystal Pharma, Inc. (Filer) CIK: 0001412486 (see all company filings)

EIN.: 352528215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38418 | Film No.: 251096840
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)